New Clinical and Real-World Data Support Use of DARZALEX®▼ (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma

December 11, 2021 09:35 AM Eastern Standard Time BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX®▼ (daratumumab)-based...

Under the MoU, the Asia Pacific Center of Excellence in Translational Science (AP CoE-TS) under Janssen AP R&D will work with OrigiMed in harnessing real-world data (RWD) for regulatory use and apply innovative applications to accelerate clinical development.

Pharmaceutical giant Johnson & Johnson has strengthened cooperation with Shanghai to further drive local innovative health-care solutions. Janssen (China) Research and Development Center of Johnson & Johnson (China) Investment Co...